Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014322 |
| CAS No | NA |
| Mol.F. | C20H22N8O8 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014323 |
| CAS No | NA |
| Mol.F. | C20H21N9O9 |
| Mol.Wt. | 531.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014324 |
| CAS No | 148950-50-9 |
| Mol.F. | C9H7Cl2N5O2 |
| Mol.Wt. | 288.1g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014325 |
| CAS No | 26360-21-4 |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014326 |
| CAS No | NA |
| Mol.F. | C12H9ClN3O6S : Na |
| Mol.Wt. | 358.73 : 22.99 |
| INV STATUS | In Stock |
| CAT No | SRC-N014327 |
| CAS No | 204268-61-1 |
| Mol.F. | C20H22N2O |
| Mol.Wt. | 306.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014328 |
| CAS No | NA |
| Mol.F. | C15H12N2O3 |
| Mol.Wt. | 268.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014329 |
| CAS No | 55556-94-0 |
| Mol.F. | C5H10N4O2 |
| Mol.Wt. | 158.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014330 |
| CAS No | NA |
| Mol.F. | C26H33N3O6 |
| Mol.Wt. | 483.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014331 |
| CAS No | NA |
| Mol.F. | C19H19N3O2 |
| Mol.Wt. | 321.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014332 |
| CAS No | NA |
| Mol.F. | C19H20FN3O3 : H2O |
| Mol.Wt. | 357.4 : 18.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014333 |
| CAS No | NA |
| Mol.F. | C20H22N8O8 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014334 |
| CAS No | NA |
| Mol.F. | C20H21N9O9 |
| Mol.Wt. | 531.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014335 |
| CAS No | NA |
| Mol.F. | C8H7F3N4O5S2 |
| Mol.Wt. | 360.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014336 |
| CAS No | NA |
| Mol.F. | C19H22N2O4 |
| Mol.Wt. | 342.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014337 |
| CAS No | NA |
| Mol.F. | C20H32N4O5 |
| Mol.Wt. | 408.5 |
| INV STATUS | CUSTOM SYNTHESIS |